Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/15951
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBROUX, Bieke-
dc.contributor.authorSTINISSEN, Piet-
dc.contributor.authorHELLINGS, Niels-
dc.date.accessioned2013-11-05T14:59:32Z-
dc.date.available2013-11-05T14:59:32Z-
dc.date.issued2013-
dc.identifier.citationCRITICAL REVIEWS IN IMMUNOLOGY, 33 (4), p. 283-306-
dc.identifier.issn1040-8401-
dc.identifier.urihttp://hdl.handle.net/1942/15951-
dc.description.abstractMultiple sclerosis (MS) is a complex disease of the central nervous system (CNS), which is believed to be immune-mediated. While CD4(+) T cells have been the main suspects for years, there is ample evidence that other immune cells (including those of the innate immune system) play a contributing or regulating role in this disease. After a general introduction, this review focuses on different immune cell subsets implicated in MS pathogenesis and on current and future possibilities to target them for therapeutic use.-
dc.language.isoen-
dc.titleWhich Immune Cells Matter? The Immunopathogenesis of Multiple Sclerosis-
dc.typeJournal Contribution-
dc.identifier.epage306-
dc.identifier.issue4-
dc.identifier.spage283-
dc.identifier.volume33-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.isi000325189900001-
item.fulltextNo Fulltext-
item.validationecoom 2014-
item.accessRightsClosed Access-
item.fullcitationBROUX, Bieke; STINISSEN, Piet & HELLINGS, Niels (2013) Which Immune Cells Matter? The Immunopathogenesis of Multiple Sclerosis. In: CRITICAL REVIEWS IN IMMUNOLOGY, 33 (4), p. 283-306.-
item.contributorBROUX, Bieke-
item.contributorSTINISSEN, Piet-
item.contributorHELLINGS, Niels-
crisitem.journal.issn1040-8401-
crisitem.journal.eissn2162-6472-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.